Clinical Trials on Melanoma, Stage II in Australia
Total 510 results
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Immutep Australia Pty. Ltd.CompletedStage IV Melanoma | Stage III MelanomaAustralia
-
Evaxion Biotech A/SMerck Sharp & Dohme LLCRecruitingMelanoma Stage IV | Melanoma Stage IIIAustralia
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIAustria, Netherlands, Australia, Sweden
-
Evaxion Biotech A/SNovotech (Australia) Pty LimitedTerminatedMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Melanoma and Skin Cancer Trials LimitedBristol-Myers Squibb; Amgen; Peter MacCallum Cancer Centre, AustraliaActive, not recruitingMelanoma | Melanoma Stage Iv | Melanoma Stage IiiAustralia
-
Medical University of ViennaCompletedStage IV Melanoma | Stage III MelanomaAustria
-
Medical University of GrazBristol-Myers SquibbTerminatedMalignant Melanoma Stage III | Malignant Melanoma Stage IV | Fecal Microbiota TransplantationAustria
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCActive, not recruitingMelanoma Stage IIIAustralia
-
Melanoma and Skin Cancer Trials LimitedNorfolk and Norwich University Hospitals NHS Foundation Trust; Canadian Cancer... and other collaboratorsRecruitingCutaneous Melanoma, Stage IIUnited States, Canada, United Kingdom, Australia, Italy, Sweden, Netherlands, New Zealand
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruitingMelanoma Stage IvAustralia, Norway
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMelanoma Stage IV | Melanoma Stage IIIAustria, Germany, Switzerland
-
ViralyticsCompletedStage IV MelanomaAustralia
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Mucosal Melanoma | Stage IIIA Skin MelanomaUnited States, Australia
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingStage III/IV MelanomaUnited States, Australia, Canada, Italy, Switzerland
-
BioNTech SERegeneron PharmaceuticalsActive, not recruitingUnresectable Melanoma | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, Italy, Australia, United Kingdom, Poland
-
Eisai Inc.CompletedStage IV Melanoma | Unresectable Stage IIIUnited States, United Kingdom, Australia, Germany
-
Saint John's Cancer InstituteMelanoma Research AllianceTerminatedStage IV Resectable MelanomaUnited States, Australia, Israel, Italy, Netherlands
-
Bristol-Myers SquibbActive, not recruiting
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, France, Australia, Italy, Greece, Israel, Russian Federation, New Zealand, Austria, United Kingdom, Netherlands, Portugal, Poland, Czechia, Romania
-
Ludwig Institute for Cancer ResearchBristol-Myers SquibbTerminatedMetastatic MelanomaAustralia
-
Cooperative Research Centre for Biomedical Imaging...Unknown
-
AmgenCompletedCompletely Resectable Stage IIIB, IIIC, or IVM1a MelanomaUnited States, Poland, France, Russian Federation, Spain, Australia, Greece, Switzerland, Brazil
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCNot yet recruitingMucosal MelanomaAustralia
-
Melanoma and Skin Cancer Trials LimitedNorfolk and Norwich University Hospitals NHS Foundation Trust; Peter MacCallum...Active, not recruitingCutaneous Melanoma by AJCC V7 StageUnited Kingdom, United States, Sweden, Australia, Canada
-
Lipotek Pty LtdRoyal Adelaide Hospital; Trident Clinical Research Pty LtdCompleted
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Anthony Joshua, FRACPSt Vincent's Hospital, SydneyActive, not recruiting
-
AmgenCompletedUnresected Stage IIIb to IVM1c MelanomaFrance, Poland, Italy, Russian Federation, Netherlands, Spain, United States, Austria, Belgium, United Kingdom, Germany, Hungary, Greece
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedUnspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)Australia, United States
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIUnited States, Netherlands, Australia
-
Olivia Newton-John Cancer Research InstituteBristol-Myers Squibb; Barwon Health; Austin Health; Eastern Health; Fiona Stanley... and other collaboratorsRecruitingFollicular Lymphoma Stage II | Follicular Lymphoma Stage III | Follicular Lymphoma Stage IVAustralia
-
University of SydneyMelanoma and Skin Cancer Trials LimitedCompleted
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
Medical University of ViennaTerminated
-
Novo Nordisk A/SCompleted
-
Peter MacCallum Cancer Centre, AustraliaRecruiting
-
Medical University of ViennaRecruitingUveal MelanomaAustria
-
Bristol-Myers SquibbCompleted
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
Medical University of GrazCompleted
-
Melanoma and Skin Cancer Trials LimitedMonash UniversityCompletedSkin Cancer | Melanoma (Skin)Australia
-
Hoffmann-La RocheCompletedUveal Melanoma | Cutaneous Melanoma | Mucosal MelanomaSpain, United States, Belgium, Denmark, Canada, Australia
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute Australia; Cancer Council New South WalesActive, not recruitingMetastatic Melanoma to the Groin Lymph NodesUnited Kingdom, Slovenia, Australia, Brazil, Netherlands, Italy
-
Ludwig Institute for Cancer ResearchAustin Health; Peter MacCallum Cancer InstituteCompleted
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedMelanomaAustralia, United States